Læknablaðið - 01.03.2014, Blaðsíða 23

LÆKNAblaðið 2014/100 151
ENGLISH SUMMARY
introduction: Amniocentesis and chorionic villus sampling (CVS) are
methods for fetal chromosomal diagnosis. Pregnant women aged ≥35
years have been offered amniocentesis in Iceland for over 35 years. The
main testing indication was maternal age until 1998, when universal
early screening was introduced. We examined outcome and fetal loss
following amniocentesis and CVS in singleton and twin pregnancies, age
distribution changes, reasons for the procedures and fetal karyotype
diagnoses.
Material and methods: Retrospective quantitative study on women
who had amniocentesis and CVS (n=2323) in the Prenatal Diagnosis
Unit at Landspitali University Hospital during 1998-2007. Unit files and
individual case and maternity records were used to retrieve information
on the indications and on maternal age, type of procedure, outome of
pregnancy, and the fetal karyotype.
Results: The number of procedures was substantially reduced from
over 500 to just over 100 per year, with a proportional shift to CVS.
Procedure-related fetal loss was 22/2323 (0.9%), with no significant
difference between amniocentesis (0.8%) and CVS (1.3%). The diffe-
rence decreased in the latter half of the study period to 0.7% and 0.8%,
respectively. Age-related reasons decreased from 81.2% to 30.8%.
Conclusion: The fetal loss incidence rates indicated that amniocentesis
and CVS have the same safety level as elsewhere. Complications were
uncommon. With CVS fetal screening was moved to an earlier time in
pregnancy. Early screening has changed the maternal age profile and is
available to all women on request. The information obtained can be used
to improve service information.
Fetal loss after amniocentesis and chorionic villus sampling in iceland
Kristin Rut Haraldsdottir, Helga Gottfredsdottir, Reynir Tomas Geirsson
keywords: Amniocentesis, chorion villus sampling, miscarriage, fetal loss, singelton pregnancy, twins.
Correspondence: Kristín Rut Haraldsdóttir, krruthar@landspitali.is
1Faculty of Nursing, Department of Midwifery, University of Iceland, 2Women´s Clinic, Landspitali University Hospital, 3Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Heimildir
1. Jóhannsson JH. Litningarannsóknir til fósturgreiningar.
Læknablaðið 2001; 87: 451-3.
2. Tabor A, Madsen M, Obel E, Philip J, Bang J, Nörgaard-
Pedersen B. Randomised controlled trial of genetic
amniocentesis in 4606 low-risk women. Lancet 1986; 1:
1287-93.
3. Harðardóttir H. Þróun fósturgreiningar. Læknablaðið
2001; 87: 399-400.
4. Cullen MT, Gabrielli S, Green JJ, Rizzo N, Mahoney
MJ, Salafia, C, et.al. Diagnosis and significance of cystic
hygroma in the first trimester. Prenat Diagn 1990; 10: 643-
51.
5. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks
K. Fetal nuchal translucency: ultrasound screening for
chromosomal defects in first trimester of pregnancy. BMJ
1992; 304: 867-9.
6. Szabo J, Gellen J. Nuchal fluid accumulation in trisomy-21
detected by vaginal sonography in first trimester. Lancet
1990; 336: 1133.
7. Nicolaides KH, Sebire NJ, Snijders RJM. The 11-14 seek
scan. The diagnosis of fetal abnormalities. Parthenon
Publishing Group, New York 1999.
8. Gaudry P, Grange G, Lebbar A, Choiset A, Girard S,
Goffinet F, et.al. Fetal loss after amniocentesis in a series
of 5,780 procedures. Fetal Diagn Ther 2008; 23: 217-21.
9. Tabor A, Vestergaard CH, Lidegaard O. Fetal loss rate
after chorionic villus sampling and amniocentesis:
an 11-year national registry study. Ultrasound Obstet
Gynecol 2009; 34: 19-24.
10. Mujezinovic F, Alfirevic Z. Procedure-Related
Complications of Amniocentesis and Chorionic Villous
Sampling: A Systematic Review. Obstet Gynecol 2007; 110:
687-94.
11. Tabor A, Alfirevic Z. Update on Procedure-Related Risks
for Prenatal Diagnosis Techniques. Fetal Diagn Ther 2010;
27: 1-7.
12 Lög um fæðingar- og foreldraorlof nr. 95/2000. Andvana
fæðing og fósturlát. althingi.is
13. Bjarnadóttir RI, Garðarsdóttir G, Smárason AK, Pálsson
GI. Skýrsla frá Fæðingaskráningunni fyrir árið 2010.
Kvennadeild og vökudeild Barnaspítala Hringsins,
Landspítali Háskólasjúkrahús, Reykjavík 2011.
14. Lander T. Neonatal and perinatal mortality: country,
regional and global estimates 2006. World Health
Organization 2006.
15. Cahill AG, Macones GA, Stamilio DM, Dicke JM, Crane
JP, Odibo AO. Pregnancy loss rate after mid-trimester
amniocentesis in twin pregnancies. Am J Obstet Gynecol
2009; 200: 257, e1-6.
16. Simonazzi G, Curti A, Farina A, Pilu G, Bovicelli L, Rizzo
N. Amniocentesis and chorionic villus sampling in twin
gestations: which is the best sampling technique? Am J
Obstet Gynecol 2010; 202: 365.
17. Royal College of Obstetricians and Gynaecologists.
Amniocentesis and chorionic villus sampling. Green-top
Guideline nr. 8. June. RCOG Press, London 2010.
18. Cebesoy FB, Balat O, Pehlivan S, Kutlar I, Dikensoy E,
Ugur MG. Is pregnancy loss after amniocentesis related
to the volume of amniotic fluid obtained? Arch Gynecol
Obstet 2009; 279: 357-60.
19. Marttala J, Ranta JK, Kaijomaa M, Nieminen P, Laitinen P,
Kokkonen H, et. al. More invasive procedures are done to
detect each case of Down´s syndrome in younger women.
Acta Obstet Gynecol Scand 2011; 90: 642-7.
20. Grande M, Arigita M, Borobio V, Jimenez JM, Fernandez
S, Borrell A. First-trimester detection of structural abnor-
malities and the role of aneuploidy markers. Ultrasound
Obstet Gynecol 2012; 39: 157-63.
R A N N S Ó K N